BRIEF published on 06/18/2024 at 07:05, 1 year 9 months ago EUROAPI et Priothera s'associent au CDMO pour faire progresser le projet d'oncologie CDMO Oncologie EUROAPI Priothera Mocravimod
BRIEF published on 06/18/2024 at 07:05, 1 year 9 months ago EUROAPI and Priothera Enter CDMO Collaboration to Advance Oncology Project CDMO Oncology EUROAPI Priothera Mocravimod
PRESS RELEASE published on 06/18/2024 at 07:00, 1 year 9 months ago EUROAPI and Priothera enter into CDMO collaboration to advance oncology project EUROAPI and Priothera have entered a 5-year CDMO collaboration to advance an innovative oncology molecule for blood cancers, aiming to improve CAR-T cell therapies EUROAPI Priothera Mocravimod CDMO Collaboration Oncology Project
BRIEF published on 06/06/2024 at 17:58, 1 year 10 months ago EUROAPI accélère les discussions de financement pour le projet FOCUS-27 Financement Transformation Stratégique EUROAPI FOCUS-27
BRIEF published on 06/06/2024 at 17:58, 1 year 10 months ago EUROAPI Accelerates Financing Discussions for FOCUS-27 Project Financing Strategic Transformation EUROAPI FOCUS-27
PRESS RELEASE published on 06/06/2024 at 17:53, 1 year 10 months ago Information marché Financement du projet de transformation FOCUS-27 EUROAPI a mandaté un tiers pour le financement de son projet stratégique FOCUS-27. Des progrès importants ont été réalisés. Découvrez les détails de cette démarche Financement EUROAPI FOCUS-27 Mandataire Ad Hoc Projet De Transformation
PRESS RELEASE published on 06/06/2024 at 17:53, 1 year 10 months ago Market update : FOCUS-27 transformation project financing EUROAPI appoints mandataire ad hoc for FOCUS-27 project financing discussions, making substantial progress. Learn more about EUROAPI and its active ingredient solutions Project Financing EUROAPI FOCUS-27 Mandataire Ad Hoc Active Ingredient Solutions
BRIEF published on 06/06/2024 at 07:05, 1 year 10 months ago EUROAPI Reaches Major Health IPCEI Milestone with Official Notification from European Commission Pharmaceutical Industry European Commission EUROAPI IPCEI Public Funding
BRIEF published on 06/06/2024 at 07:05, 1 year 10 months ago EUROAPI franchit une étape majeure de l'IPCEI en matière de santé avec une notification officielle de la Commission européenne Industrie Pharmaceutique EUROAPI Commission Européenne IPCEI Financement Publique
PRESS RELEASE published on 06/06/2024 at 07:00, 1 year 10 months ago EUROAPI reaches major Health IPCEI milestone with official notification from European Commission EUROAPI selected for EUR 1 billion IPCEI funding by European Commission to enhance pharmaceutical sector competitiveness and sustainability European Commission R&D EUROAPI IPCEI Pharmaceutical Sector
Published on 04/08/2026 at 23:00, 2 hours 13 minutes ago NXT Energy Solutions Announces SFD Survey Contract
Published on 04/08/2026 at 22:05, 3 hours 8 minutes ago GameSquare Achieves First Positive Adjusted EBITDA Quarter in Fourth Quarter, Marking Inflection to Operating Profitability
Published on 04/08/2026 at 18:45, 6 hours 28 minutes ago Nano One to Receive Additional C$4.3M from the Government of Canada to Advance Battery Material Production for Energy Security & Defence
Published on 04/08/2026 at 18:45, 6 hours 28 minutes ago Nano One recevra 4,3 M$ supplémentaires du gouvernement du Canada pour faire avancer la production de matériaux de batterie pour la sécurité énergétique et la défense
Published on 04/08/2026 at 16:08, 9 hours 5 minutes ago Super Copper Announces Investor Relations Agreement
Published on 04/08/2026 at 23:54, 1 hour 19 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: Raiffeisen Bank International AG announces its intention to launch a voluntary takeover offer to the shareholders of Addiko Bank AG
Published on 04/08/2026 at 23:30, 1 hour 43 minutes ago AMPERA Officially Opens World Headquarters in Florida
Published on 04/08/2026 at 23:21, 1 hour 51 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: RBI announces intention to submit a voluntary public tender offer for all Addiko shares at EUR 23.05 per share
Published on 04/08/2026 at 21:03, 4 hours 9 minutes ago EQS-Adhoc: Elmos Semiconductor SE: Cancellation of 540,000 treasury shares (approx. 3.05% of the share capital)
Published on 04/08/2026 at 18:10, 7 hours 3 minutes ago PolyPeptide announces results of the annual General Meeting 2026
Published on 04/08/2026 at 18:17, 6 hours 55 minutes ago Mise à disposition du Rapport sur la solvabilité et la situation financière 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:16, 6 hours 56 minutes ago Mise à disposition des états financiers 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:02, 7 hours 11 minutes ago Publication of the 2025 Universal Registration Document
Published on 04/08/2026 at 18:02, 7 hours 11 minutes ago Mise à disposition du Document d'Enregistrement Universel 2025
Published on 04/08/2026 at 17:45, 7 hours 28 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
